Medicare Enrolled
Dr. John Bahadorani, M.D.
Cardiovascular Disease · La Jolla, CA
Practice pattern: Remote & Electrophysiology
— Practice combining remote and electrophysiology services
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Bahadorani from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bahadorani?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Bahadorani
Dr. John Bahadorani is a cardiovascular disease specialist in La Jolla, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Bahadorani performed 3,674 Medicare services across 2,378 unique beneficiaries.
Between the years covered by Open Payments, Dr. Bahadorani received a total of $57,683 from 63 pharmaceutical and/or device companies across 986 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Bahadorani is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 29% volume in CA
$57,683 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,674
Medicare services
Top 29% in CA for cardiovascular disease
2,378
Unique beneficiaries
$90
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~204 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
595 | $12 | $26 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
580 | $100 | $150 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
239 | $7 | $55 |
| Remote monitoring of implantable heart device, up to 30 days Remote evaluation of an implanted heart or blood vessel monitoring system over a period of up to 30 days. |
204 | $21 | $39 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
204 | $100 | $130 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
175 | $171 | $269 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
168 | $142 | $233 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
164 | $73 | $109 |
| Remote patient monitoring device, 30 days Initial setup of devices for remote monitoring of body functions with daily data transmission or alerts. This service covers the first 30 days of the monitoring period. |
155 | $43 | $70 |
| Remote patient monitoring management, 20 min/month Management based on results from remote vital sign monitoring for the first 20 minutes per calendar month. |
150 | $41 | $60 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
121 | $125 | $191 |
| Remote pacemaker monitoring, 90 days Remote assessment of a pacemaker system, including single, dual, multiple lead, or leadless devices, performed up to 90 days apart. |
85 | $24 | $40 |
| Principal care management for high-risk disease, first 30 minutes This service covers the initial 30 minutes of clinical staff time per calendar month to manage a single high-risk disease. It is directed by a healthcare professional. |
73 | $49 | $65 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
70 | $20 | $40 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
68 | $783 | $1,100 |
| Regadenoson injection (Lexiscan) for heart stress test An injection of regadenoson, a medication used to stress the heart during diagnostic testing. |
64 | $40 | $65 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
59 | $41 | $89 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
59 | $20 | $62 |
| Stress echocardiogram with ECG monitoring An ultrasound of the heart performed while monitoring heart rhythm during rest, exercise, or medication-induced stress, followed by a review and report of the findings. |
58 | $206 | $343 |
| Cardiac catheterization | 47 | $186 | $465 |
| Ultrasound of head and neck blood flow, bilateral An ultrasound exam that uses sound waves to visualize and assess blood flow in the vessels of both the head and the neck. |
36 | $169 | $280 |
| Remote physiologic monitoring setup and education Initial setup of remote monitoring equipment and patient education on its use. |
34 | $17 | $25 |
| Technetium Tc-99m sestamibi diagnostic injection A diagnostic injection of technetium Tc-99m sestamibi used for imaging studies. |
32 | $102 | $150 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
31 | $88 | $141 |
| Repair of left upper heart chamber with implant A surgical procedure to repair the left upper chamber of the heart using an implanted device, with review by a radiologist. |
26 | $398 | $650 |
| Remote vital sign monitoring management, each additional 20 minutes This code covers the time spent by a provider managing patient data from remote vital sign monitoring devices. It applies to each additional 20-minute increment beyond the initial monthly service period. |
24 | $34 | $50 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
23 | $459 | $707 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
22 | $106 | $144 |
| Ultrasound of heart blood vessel or graft An ultrasound exam to evaluate blood flow in a heart blood vessel or graft, including a radiologist's review of the initial vessel. |
18 | $76 | $120 |
| Coronary angiography A procedure to insert a tube into a coronary artery to capture diagnostic images of the heart's blood vessels. |
18 | $127 | $300 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram under physician supervision and review. |
17 | $63 | $120 |
| Nuclear stress test of heart muscle A nuclear medicine imaging test that evaluates blood flow to the heart muscle at rest and during stress using a special camera. |
16 | $405 | $581 |
| Transcatheter aortic valve replacement via femoral artery A minimally invasive procedure to replace a diseased aortic heart valve using a catheter inserted through the skin and femoral artery. |
14 | $604 | $1,450 |
| Ultrasound of leg arteries or grafts An imaging test that uses sound waves to create pictures of the blood vessels in the legs or any surgical grafts present. |
13 | $222 | $320 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
12 | $70 | $100 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.3% high complexity
9.4% medium
79.3% routine
Industry Payment Transparency
Open Payments through 2024 ↗$57,683
Total received (2018-2024)
Avg $8,240/year across 7 years
Top 9% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
63
Companies
986
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$29,478 (51.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$28,204 (48.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$3,799
2023
$3,429
2022
$7,182
2021
$9,390
2020
$7,944
2019
$12,561
2018
$13,378
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$498
BIOTRONIK INC.
$477
ABIOMED
$249
ShockWave Medical, Inc
$232
Boston Scientific Corporation
$208
Medtronic, Inc.
$200
Alnylam Pharmaceuticals Inc.
$196
Novartis Pharmaceuticals Corporation
$188
Inari Medical, Inc.
$174
Biosense Webster, Inc.
$150
Kiniksa Pharmaceuticals International, plc
$142
SCPHARMACEUTICALS INC.
$142
Amgen Inc.
$126
E.R. Squibb & Sons, L.L.C.
$102
CARDIVA MEDICAL, INC.
$99
Merck Sharp & Dohme LLC
$90
Boehringer Ingelheim Pharmaceuticals, Inc.
$85
PFIZER INC.
$66
Kestra Medical Technology Services, Inc.
$59
AstraZeneca Pharmaceuticals LP
$56
Janssen Pharmaceuticals, Inc
$48
Novo Nordisk Inc
$46
SANOFI-AVENTIS U.S. LLC
$38
Bayer Healthcare Pharmaceuticals Inc.
$31
Actelion Pharmaceuticals US, Inc.
$30
Edwards Lifesciences Corporation
$28
CVRx, Inc.
$25
Esperion Therapeutics, Inc.
$15
Top 3 companies account for 32.2% of 2024 payments
All-time payments by company (2018-2024) ›
BIOTRONIK INC.
$17,165
Astellas Pharma US Inc
$14,198
Penumbra, Inc.
$2,893
ABIOMED
$1,799
Abbott Laboratories
$1,687
AstraZeneca Pharmaceuticals LP
$1,618
Amgen Inc.
$1,469
Chiesi USA, Inc.
$1,374
Boston Scientific Corporation
$1,235
CHIESI USA, INC.
$1,092
Novartis Pharmaceuticals Corporation
$965
SANOFI-AVENTIS U.S. LLC
$718
Shockwave Medical, Inc
$705
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$696
PFIZER INC.
$689
Impulse Dynamics (USA) Inc.
$676
Janssen Pharmaceuticals, Inc
$610
E.R. Squibb & Sons, L.L.C.
$582
Boehringer Ingelheim Pharmaceuticals, Inc.
$566
Alnylam Pharmaceuticals Inc.
$509
Cardiovascular Systems Inc.
$469
Inari Medical, Inc.
$438
Medtronic, Inc.
$424
Otsuka America Pharmaceutical, Inc.
$383
Medtronic Vascular, Inc.
$356
Regeneron Healthcare Solutions, Inc.
$340
Novo Nordisk Inc
$326
Amarin Pharma Inc.
$293
Merck Sharp & Dohme LLC
$290
ShockWave Medical, Inc
$232
Esperion Therapeutics, Inc.
$210
Haemonetics Corporation
$201
Gilead Sciences, Inc.
$182
CARDIVA MEDICAL, INC.
$181
SCPHARMACEUTICALS INC.
$180
Kestra Medical Technology Services, Inc.
$158
Biosense Webster, Inc.
$150
Edwards Lifesciences Corporation
$143
Kiniksa Pharmaceuticals International, plc
$142
Bayer HealthCare Pharmaceuticals Inc.
$133
Acutus Medical, Inc.
$130
Kiniksa Pharmaceuticals, Ltd.
$127
CVRx, Inc.
$102
Tactile Systems Technology Inc
$101
BOSTON SCIENTIFIC CORPORATION
$82
ARBOR PHARMACEUTICALS, INC.
$76
Merck Sharp & Dohme Corporation
$68
Actelion Pharmaceuticals US, Inc.
$67
Bayer Healthcare Pharmaceuticals Inc.
$66
AtriCure, Inc.
$48
Cardinal Health 200, LLC
$48
Azurity Pharmaceuticals, Inc.
$47
ACIST MEDICAL SYSTEMS, INC.
$38
Preventice Services, LLC
$32
Arbor Pharmaceuticals, Inc.
$28
Bardy Diagnostics, Inc.
$26
Celgene Corporation
$23
Acist Medical Systems, Inc.
$22
InfoBionic, Inc
$21
Lundbeck LLC
$15
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$15
Itamar Medical Inc
$14
Allergan Inc.
$11
Top 3 companies account for 59.4% of all-time payments
Associated products mentioned in payments ›
AMPLATZER AMULET · AMVIA EDGE · AMVUTTRA · ASSURITY · ATRICURE ATRICLIP LAA EXCLUSION · AVEIR · AVVIGO Guidance System · Acticor · Acticor 7 VR-T DX · Arcalyst · Assure WCD · Astron; Pulsar; AstronPulsar · AtriCure Synergy Ablation System · Axium · BG Mini Plus · BIOMONITOR · BRILINTA · BYSTOLIC · Barostim Neo System · BioMonitor · BodyGuardian · CAMZYOS · CARDIVA VASCADE 6/7F VCS · CARDIVA VASCADE MVP VVCS 6-12F · CARTO 3 · CHANTIX · CONFIRM RX · COREVALVE EVOLUT R · CT THROMBECTOMY SYSTEM KIT · CVI Consumables · CardioMEMS HF System · Carnation Ambulatory Monitor · Confirm Rx · CoreValve Evolut · Corlanor · Coronary Orbital Atherectomy System · Diamondback Coronary · EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) · ELIQUIS · ENSITE · ENTRESTO · EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX · EVKEEZA · Edarbi · Edarbyclor · Edora · Edora 8 DR-T · Ellipse ICD · FARXIGA · FLEXITOUCH · FLOWTRIEVER CATHETER · FUROSCIX · Flexitouch Plus · Fortify Assura · GENERAL TACHY · HD-IVUS · HawkOne · HeartWare HVAD · Impella · Indigo · JARDIANCE · JOT DX · KENGREAL · KENGREAL 50MG/10ML L · Kerendia · LEQVIO · LEXISCAN · LUX-Dx Insertable Cardiac Monitor · Lexiscan · LifeVest · MICRA · MITRACLIP · MULTAQ · Mitra Clip system · MitraClip System · MoMe Kardia · NEXLETOL · NORTHERA · ONPATTRO · OPSUMIT · OPTIMIZER · OPTOWIRE · Optimizer · Orsiro · Orsiro Mission · Ozempic · PK Papyrus · PORTICO · PRADAXA · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Passeo-18 · Peripheral Orbital Atherectomy System · Pulsar · Pulsar-18 T3 · RELISTOR ORAL · RESOLUTE ONYX · ROTAPRO · Repatha · Resolute · Reveal LINQ · Rivacor · Rivacor 7 DR-T · S · SAMSCA · SAPIEN 3 Ultra RESILIA · SHOCKWAVE IVL SYSTEM WITH THE SHOCKWAVE C2 CORONARY IVL CATHETER · Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter · Solia · TEG · Tryton Side Branch Stent · VENASEAL · VERQUVO · VIAGRA · VYNDAMAX · VYNDAQEL · Vascepa · WAINUA · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · WatchPAT · Wegovy · XARELTO · XIENCE SIERRA · Xience Sierra Coronary Stent · Xience Sierra Coronary Stent System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (51%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 9% for cardiovascular disease in CA.
Geographic Context
Cardiologists within 10 mi
248
Per 100K population
7.6
County median income
$102,285
Nearest hospital
SCRIPPS MEMORIAL HOSPITAL LA JOLLA
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Bahadorani is a remote & electrophysiology specialist, with above-average Medicare volume (top 29% in CA), with low-engagement industry engagement in the top 9% of CA peers, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Bahadorani experienced with electrocardiogram (ekg), 12-lead?
Based on Medicare claims data, Dr. Bahadorani performed 595 electrocardiogram (ekg), 12-lead services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bahadorani receive payments from pharmaceutical companies?
Yes. Dr. Bahadorani received a total of $57,683 from 63 companies across 986 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bahadorani's costs compare to other cardiologists in La Jolla?
Dr. Bahadorani's average Medicare payment per service is $90. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bahadorani) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in La Jolla
Browse cardiologists in La Jolla ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
BIOTRONIK INC. Payments to Doctors
See all physicians who received payments from BIOTRONIK INC.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Penumbra, Inc. Payments to Doctors
See all physicians who received payments from Penumbra, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology